Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease (Q47759490)
scientific article published in April 1971
Language:
Current Data About Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease
(P31) (Q13442814)
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P50) (Q43042765)
(P1545) 1
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P304) 515-521
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P407) (Q1860)

(P433) 4
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P478) 32
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P577) Thursday, April 1, 1971
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P921) (Q181600)

(P1433) (Q3186902)
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P1476) "Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease" (language: en)
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

(P2093) Ingbar SH
(P1545) 2
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

Vagenakis AG
(P1545) 3
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

Adams L
(P1545) 4
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

Maloof F
(P1545) 5
(P248)
(P698) 4926257
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/4926257

other details
description scientific article published in April 1971

External Links
(P356) 10.1210/JCEM-32-4-515
(P698) 4926257